Literature DB >> 1642252

Case report: coronary vasospasm--relation to the hyperthyroid state.

D Moliterno1, C R DeBold, R M Robertson.   

Abstract

While angina is not uncommonly seen in association with hyperthyroidism, only rare case reports have suggested that myocardial ischemia in this state may be due to coronary artery spasm. The authors review the literature and describe a case in which the repetitive occurrence of episodes of myocardial ischemia due to coronary spasm correlated with repeated transient elevations in thyroid hormone levels, thus clarifying this relationship. The importance of defining thyroid status in patients presenting with coronary vasospasm is emphasized and the effects of thyroid hormone on the heart are reviewed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642252     DOI: 10.1097/00000441-199207000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Vasospastic angina in a patient with hyperthyroidism.

Authors:  U Canpolat; H Sunman; K M Gürses; K Aytemir
Journal:  Herz       Date:  2012-03-11       Impact factor: 1.443

2.  Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction.

Authors:  N D Masani; D B Northridge; R J Hall
Journal:  Br Heart J       Date:  1995-12

3.  Isolated right ventricular failure in hyperthyroidism: a clinical dilemma.

Authors:  Ryan J McDonough; Marvin S Moul; Darrick Beckman; Ahmad M Slim
Journal:  Heart Int       Date:  2011-10-21

4.  Takotsubo cardiomyopathy in a patient with multiple autoimmune disorders and hyperthyroidism.

Authors:  Murat Ugurlucan; Yilmaz Zorman; Gursel Ates; Ahmet H Arslan; Yahya Yildiz; Aysegul Karahan Zor; Sertac Cicek
Journal:  Res Cardiovasc Med       Date:  2013-07-31

Review 5.  Association of Endocrine Conditions With Takotsubo Cardiomyopathy: A Comprehensive Review.

Authors:  Sonali Gupta; Pradeep Goyal; Sana Idrees; Sourabh Aggarwal; Divyansh Bajaj; Joseph Mattana
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.